1. September 9, 2021

    Unavailability of RoActemra (Roche): update on the situation

    RoActemra (tocilizumab), een geneesmiddel dat wordt gebruikt voor bepaalde reumatologische en hematologische aandoeningen, is momenteel wereldwijd onbeschikbaar. 

    RoActemra (tocilizumab), un médicament utilisé pour traiter certaines affections rhumatismales et hématologiques, est actuellement indisponible dans le monde entier.

    Source: FAMHP

    Read more

  2. September 3, 2021

    Coronavirus: new version of Belgian directive for management of clinical trials during coronavirus pandemic

    A new version of the national directive is available to supplement the European guidelines (v3) for the management of clinical trials during the coronavirus pandemic.

    Source: FAMHP

    Read more

  3. August 30, 2021

    Coronavirus: biweekly update of COVID-19 vaccines 26 August 2021

    Coronavirus: tweewekelijks overzicht bijwerkingen COVID-19-vaccins van 26 augustus 2021

    Coronavirus : aperçu bimensuel des effets indésirables des vaccins contre la COVID-19 du 26 août 2021

    Source: FAMHP

    Read more

  4. August 25, 2021

    News from IFAPP

    Paper on Promoting Best Practices for Medical Science Liaisons, Position
    Statement from the APPA, IFAPP, MAPS and MSLS

    Read more

  5. August 17, 2021

    Fraudulent e-mails in the name of the FAMHP

    Frauduleuze e-mails in naam van het FAGG

    E-mails frauduleux au nom de l'AFMPS

    Source: FAMHP

    Read more

  6. August 17, 2021

    Coronavirus: biweekly update of COVID-19 vaccines 12 August 2021

    Coronavirus: tweewekelijks overzicht bijwerkingen COVID-19-vaccins van 12 augustus 2021

    Coronavirus : aperçu bimensuel des effets indésirables des vaccins contre la COVID-19 du 12 août 2021

    Source: FAMHP

    Read more

  7. August 17, 2021

    PRAC August 2021 – Recommendation and review of safety issues related to COVID-19 vaccines

    During its August 2021 meeting, the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) recommended updating the product information of COVID-19 Vaccine Janssen.

    Source: FAMHP

    Read more

  8. August 17, 2021

    Coronavirus: biweekly update of COVID-19 vaccines dated 29 July 2021

    Coronavirus: tweewekelijks overzicht bijwerkingen COVID-19-vaccins van 29 juli 2021

    Coronavirus : aperçu bimensuel des effets indésirables des vaccins contre la COVID-19 du 29 juillet 2021

    Source: FAMHP

    Read more

  9. August 17, 2021

    Limited availability of RoActemra (Roche): recommendations for (hospital) pharmacists, general practitioners and physician specialists.

    The stock of RoActemra, a medicinal product used for certain rheumatological and haematological disorders, is currently limited worldwide. The Federal Agency for Medicines and Health Products (FAMHP) therefore issues recommendations.

    Source: FAMHP

    Read more

  10. August 17, 2021

    Updated guidance for submission of clinical trial applications, substantial amendment notifications and end of trial declarations to the FAMHP

    A new version of the guidance for submission of clinical trial applications, substantial amendment notifications and end of trial declarations to the FAMHP is available.

    Source: FAMHP

    Read more